- Home
- STCN vs GNTA Comparison
STCN vs GNTA Comparison
Compare STCN & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STCN
- GNTA
- Stock Information
- Founded
- STCN 1986
- GNTA 2014
- Country
- STCN United States
- GNTA Italy
- Employees
- STCN N/A
- GNTA N/A
- Industry
- STCN Advertising
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STCN Consumer Discretionary
- GNTA Health Care
- Exchange
- STCN Nasdaq
- GNTA Nasdaq
- Market Cap
- STCN 63.4M
- GNTA 67.4M
- IPO Year
- STCN 1994
- GNTA 2021
- Fundamental
- Price
- STCN $10.40
- GNTA $5.34
- Analyst Decision
- STCN
- GNTA Strong Buy
- Analyst Count
- STCN 0
- GNTA 1
- Target Price
- STCN N/A
- GNTA $25.00
- AVG Volume (30 Days)
- STCN 11.9K
- GNTA 28.4K
- Earning Date
- STCN 12-12-2024
- GNTA 01-01-0001
- Dividend Yield
- STCN N/A
- GNTA N/A
- EPS Growth
- STCN 203.29
- GNTA N/A
- EPS
- STCN 3.17
- GNTA N/A
- Revenue
- STCN $169,044,000.00
- GNTA N/A
- Revenue This Year
- STCN N/A
- GNTA N/A
- Revenue Next Year
- STCN N/A
- GNTA N/A
- P/E Ratio
- STCN $3.19
- GNTA N/A
- Revenue Growth
- STCN N/A
- GNTA N/A
- 52 Week Low
- STCN $7.36
- GNTA $2.20
- 52 Week High
- STCN $13.00
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- STCN 57.19
- GNTA 56.89
- Support Level
- STCN $9.90
- GNTA $4.89
- Resistance Level
- STCN $10.29
- GNTA $6.20
- Average True Range (ATR)
- STCN 0.39
- GNTA 0.70
- MACD
- STCN 0.11
- GNTA -0.06
- Stochastic Oscillator
- STCN 100.00
- GNTA 37.32
About STCN Steel Connect Inc.
Steel Connect Inc is a diversified holding company. The company's operating segment include Direct Marketing and Supply Chain. It generates maximum revenue from the Direct Marketing segment. Geographically, it derives a majority of revenue from the United States and also has a presence in China; Netherlands, and others. The company serves clients in various industries including consumer electronics, communications, computing, software, storage, and retail industries.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.